The Experts below are selected from a list of 1182 Experts worldwide ranked by ideXlab platform
Mandana Khodashahi - One of the best experts on this subject based on the ideXlab platform.
-
Efficacy of Acceptance and Commitment Therapy in Reducing Disappointment, Psychological Distress, and Psychasthenia among Systemic Lupus Erythematosus (SLE) Patients.
Iranian Journal of Psychiatry, 2019Co-Authors: Maryam Sahebari, Mohammad Javad Asghari Ebrahimabad, Ali Ahmadi Shoraketokanlo, Hamidreza Aghamohammadian Sharbaf, Mandana KhodashahiAbstract:Objective: The aim of this study was to evaluate the efficacy of acceptance and commitment therapy (ACT) in the reduction of disappointment, psychological distress, and Psychasthenia among patients with systemic lupus erythematosus (SLE). Method: This quasi-experimental study was conducted on 24 females with lupus who referred to the Rheumatoid Disease Research Center (RDRC) of Ghaem hospital in Mashhad, Iran. This study had a pretest-posttest control group design. The participants were randomly assigned into 2 groups of experimental and control. The experimental group was treated with ACT. Data were collected using the Beck's Hopelessness Scale, Kessler's Psychological Distress Inventory, and Krupp's Psychasthenia Inventory. Results: Mean age and mean duration of illness were 37.25±4.61 and 5.12±2.33 years, respectively. The mean disappointment score and psychological distress in the experimental group were lower compared to those in control group at the post experimental stage (P
-
efficacy of acceptance and commitment therapy in reducing disappointment psychological distress and Psychasthenia among systemic lupus erythematosus sle patients
Iranian Journal of Psychiatry, 2019Co-Authors: Maryam Sahebari, Mohammad Javad Asghari Ebrahimabad, Ali Ahmadi Shoraketokanlo, Hamidreza Aghamohammadian Sharbaf, Mandana KhodashahiAbstract:Objective: The aim of this study was to evaluate the efficacy of acceptance and commitment therapy (ACT) in the reduction of disappointment, psychological distress, and Psychasthenia among patients with systemic lupus erythematosus (SLE). Method: This quasi-experimental study was conducted on 24 females with lupus who referred to the Rheumatoid Disease Research Center (RDRC) of Ghaem hospital in Mashhad, Iran. This study had a pretest-posttest control group design. The participants were randomly assigned into 2 groups of experimental and control. The experimental group was treated with ACT. Data were collected using the Beck's Hopelessness Scale, Kessler's Psychological Distress Inventory, and Krupp's Psychasthenia Inventory. Results: Mean age and mean duration of illness were 37.25±4.61 and 5.12±2.33 years, respectively. The mean disappointment score and psychological distress in the experimental group were lower compared to those in control group at the post experimental stage (P<0.001). Moreover, there was a significant difference between the experimental and control groups in the mean scores of Psychasthenia in the posttest stage (P<0.001). Conclusion: According to the obtained results of this study, the enhancement of psychological flexibility based on ACT positively affected disappointment, psychological distress, and Psychasthenia among the lupus patients. Therefore, it can be concluded that this therapeutic approach could reduce Psychasthenia in patients through clarification of the values.
M. Khansari - One of the best experts on this subject based on the ideXlab platform.
-
P03-495 - Comparison of mental status in mothers and wives of addicted men, with mothers and wives of non-addicted men
European Psychiatry, 2011Co-Authors: H. Jamilian, M. KhansariAbstract:Introduction Substance abuse of main family member can affect other family members in some studies. Aims Comparing the mental status of mothers and wives of addicted men, with mothers and wives of non-addicted men. Methods In a case-control study which performed in a recovery home in Arak-Iran, In 2009, 57 mothers and wives of addicted men, and 57 mothers and wives of non-addicted men were assessed by MMPI-2 questionnaire. Data were analyzed by using SPSS V17. Results The mean scores of addicted men's mothers were significantly higher than non-addicted men's mothers in hypochondriasis, depression, psychopath deviation, paranoia, Psychasthenia, schizoid, and F scales. On the other hand, the mean scores of addicted men's wives were significantly higher than non-addicted men's wives in hypochondriasis, psychopath deviation, paranoia, Psychasthenia, schizoid, and F scales. Conclusion There are severe psychiatric problems in mothers and wives of addicted men.
-
Comparison of mental status in mothers and wives of addicted men, with mothers and wives of non-addicted men
European Psychiatry, 2011Co-Authors: H. Jamilian, M. KhansariAbstract:IntroductionSubstance abuse of main family member can affect other family members in some studies.AimsComparing the mental status of mothers and wives of addicted men, with mothers and wives of non-addicted men.MethodsIn a case-control study which performed in a recovery home in Arak-Iran, In 2009, 57 mothers and wives of addicted men, and 57 mothers and wives of non-addicted men were assessed by MMPI-2 questionnaire. Data were analyzed by using SPSS V17.ResultsThe mean scores of addicted men's mothers were significantly higher than non-addicted men's mothers in hypochondriasis, depression, psychopath deviation, paranoia, Psychasthenia, schizoid, and F scales. On the other hand, the mean scores of addicted men's wives were significantly higher than non-addicted men's wives in hypochondriasis, psychopath deviation, paranoia, Psychasthenia, schizoid, and F scales.ConclusionThere are severe psychiatric problems in mothers and wives of addicted men.
Ganry H - One of the best experts on this subject based on the ideXlab platform.
-
Efficacy of tianeptine in the treatment of Psychasthenia. A study versus placebo
L'Encephale, 1992Co-Authors: Grivois H, Deniker P, Ganry HAbstract:Tianeptine is an effective antidepressant with original neurochemical properties. Tianeptine increases the serotonin (5-HT) reuptake after acute and chronic treatment. The efficacy of tianeptine (T) versus placebo (P) was evaluated in the treatment of Psychasthenia, because of the role of 5-HT in obsessive-compulsive disorders, the last state of Psychasthenia in term of severity. Patients were recruited using the Psychasthenia scale; then, their MADRS scores limited those who turned out to the depression. Mean inclusion MADRS scores where 12 (T) and 11.8 (P). Tianeptine is an effective treatment for patients suffering from Psychasthenia. Tianeptine is more effective than placebo in global score and in sub-scores (asthenia and somatic symptoms) of the Psychasthenia scale. In spite of weak inclusion scores in MADRS, patients taking tianeptine also showed significant improvement, greater than with placebo. The percentage of patients with a reduction equal to or greater than 50% of their MADRS score was significantly more important in tianeptine group. These results could be the illustration of the decrease in associated depressive symptoms or the result of an improvement of symptoms common to MADRS and Psychasthenia scales. The same favorable results were obtained in symptoms of anxiety scored by HARS. In term of safety, tianeptine is equivalent to a placebo if we consider somatic complaints expressed by the patients, global improvement evaluated by the patient and the investigator, weight and blood pressure. Interruption of treatment for side-effects concerns the placebo group only (3 versus 0). This excellent safety is particularly well-adapted to the treatment of these out-patients.
-
A scale to assess Psychasthenia
L'Encephale, 1992Co-Authors: Deniker P, Ganry HAbstract:Psychasthenia exists--we meet it every day". Despite this affirmation, Pierre Janet's views remain unappreciated by international psychiatry. Psychasthenia is not included in the Diagnostic and Statistical Manual of Mental Disorders (DSM III-R). This pathology, described by Janet as both benign and terrible, is presently broken into many diagnostic categories with respect to the principal symptomatology of the patient. When a mood disorder is present, these patients can have diagnostic criteria for major depression or dysthymia. Patients with prevalent anxiety, phobia or obsessive-compulsive symptoms, must also be classified in having anxiety disorders. When somatic complaints are major symptoms, the patient's disease can be, on the whole, attributed to a somatoform disorder. This scale is a global evaluation of Psychasthenia. It is made up of three lists of items. The first concerns asthenia or fatigue sine materia. The items in this group allow an evaluation of the physical and mental characteristics of asthenia associated with an inability of acting. Difficulties in mental concentration are measured by items in the second list. Mental processes are associated with doubts and waverings. They are interrupted by interferences caused by obsessions with recurrent and persistent ideas, impulses or images. Physical symptoms without organic pathology or a pathophysiologic mechanism constitute the neurasthenic part of Psychasthenia. In the third list, somatic complaints are spelled out in a check-list of these potential symptoms. This scale can be used as a help in the diagnosis. Items 2, 3, 5, 25, 26 and 29 have a specific reference to the history of the disorder.(ABSTRACT TRUNCATED AT 250 WORDS)
Rafaela Teixeira Zorzanelli - One of the best experts on this subject based on the ideXlab platform.
-
Psicastenia Psychasthenia
Fundação Oswaldo Cruz Casa de Oswaldo Cruz, 2010Co-Authors: Rafaela Teixeira ZorzanelliAbstract:Analisa a categoria médica da psicastenia, utilizada no fim do século XIX e início do século XX pela psiquiatria francesa. São apresentadas as características do quadro clínico bem como as principais hipóteses explicativas para os sintomas sustentadas por Pierre Janet, principal nome ligado à sistematização dessa categoria nosológica. É discutido ainda o modo como esse diagnóstico foi utilizado no Brasil, e as suas relações com o quadro da neurastenia no contexto da psiquiatria brasileira.The article analyzes the medical category of Psychasthenia, used by French psychiatry from the late nineteenth through the early twentieth centuries. It describes the clinical profile of Psychasthenia and the main hypotheses meant to account for symptoms as defined and advanced by Pierre Janet, the central figure in systematization of this category. The article also looks at how this diagnosis was used in Brazil and how it related to the profile of neurasthenia within the context of Brazilian psychiatry
Maryam Sahebari - One of the best experts on this subject based on the ideXlab platform.
-
Efficacy of Acceptance and Commitment Therapy in Reducing Disappointment, Psychological Distress, and Psychasthenia among Systemic Lupus Erythematosus (SLE) Patients.
Iranian Journal of Psychiatry, 2019Co-Authors: Maryam Sahebari, Mohammad Javad Asghari Ebrahimabad, Ali Ahmadi Shoraketokanlo, Hamidreza Aghamohammadian Sharbaf, Mandana KhodashahiAbstract:Objective: The aim of this study was to evaluate the efficacy of acceptance and commitment therapy (ACT) in the reduction of disappointment, psychological distress, and Psychasthenia among patients with systemic lupus erythematosus (SLE). Method: This quasi-experimental study was conducted on 24 females with lupus who referred to the Rheumatoid Disease Research Center (RDRC) of Ghaem hospital in Mashhad, Iran. This study had a pretest-posttest control group design. The participants were randomly assigned into 2 groups of experimental and control. The experimental group was treated with ACT. Data were collected using the Beck's Hopelessness Scale, Kessler's Psychological Distress Inventory, and Krupp's Psychasthenia Inventory. Results: Mean age and mean duration of illness were 37.25±4.61 and 5.12±2.33 years, respectively. The mean disappointment score and psychological distress in the experimental group were lower compared to those in control group at the post experimental stage (P
-
efficacy of acceptance and commitment therapy in reducing disappointment psychological distress and Psychasthenia among systemic lupus erythematosus sle patients
Iranian Journal of Psychiatry, 2019Co-Authors: Maryam Sahebari, Mohammad Javad Asghari Ebrahimabad, Ali Ahmadi Shoraketokanlo, Hamidreza Aghamohammadian Sharbaf, Mandana KhodashahiAbstract:Objective: The aim of this study was to evaluate the efficacy of acceptance and commitment therapy (ACT) in the reduction of disappointment, psychological distress, and Psychasthenia among patients with systemic lupus erythematosus (SLE). Method: This quasi-experimental study was conducted on 24 females with lupus who referred to the Rheumatoid Disease Research Center (RDRC) of Ghaem hospital in Mashhad, Iran. This study had a pretest-posttest control group design. The participants were randomly assigned into 2 groups of experimental and control. The experimental group was treated with ACT. Data were collected using the Beck's Hopelessness Scale, Kessler's Psychological Distress Inventory, and Krupp's Psychasthenia Inventory. Results: Mean age and mean duration of illness were 37.25±4.61 and 5.12±2.33 years, respectively. The mean disappointment score and psychological distress in the experimental group were lower compared to those in control group at the post experimental stage (P<0.001). Moreover, there was a significant difference between the experimental and control groups in the mean scores of Psychasthenia in the posttest stage (P<0.001). Conclusion: According to the obtained results of this study, the enhancement of psychological flexibility based on ACT positively affected disappointment, psychological distress, and Psychasthenia among the lupus patients. Therefore, it can be concluded that this therapeutic approach could reduce Psychasthenia in patients through clarification of the values.
